The U.S. Food and Drug Administration has approved a blood test to be used for colorectal cancer screening among average-risk adults 45 and older.The maker of the test, Palo Alto, California-based ...

Approval demonstrates unique value of Shield test for CRC screening and improves Medicare pricing PALO ALTO, Calif.--(BUSINESS WIRE)-- Guardant Health, Inc. (GH), a leading precision oncology company, ...

The U.S. Food and Drug Administration on Monday morning approved a blood test to screen for colorectal cancer in certain individuals. The blood test, known as Shield and manufactured by Guardant ...

FDA reviewers questioned the potential benefits of Guardant Health's blood-based test for colorectal cancer (CRC) screening in documents released ahead of an advisory committee meeting on Thursday.

(WXYZ) — The first blood test for colon cancer is on the horizon. A study published Wednesday showed it detected the disease in more than 8 in 10 people. I do ...

A blood test to screen for colorectal cancer is one step closer to receiving approval from the U.S. Food and Drug Administration. An FDA advisory panel — the Medical Devices Advisory Committee — ...

In 2024, the Food and Drug Administration (FDA) approved a blood test that can screen for colorectal cancer in people older than 45 years old at average risk for the disease. Some people may skip ...

PALO ALTO, Calif.--(BUSINESS WIRE)-- Guardant Health, Inc. (GH), a leading precision oncology company, today announced new real-world data published in Current Medical Research and Opinion finding ...